Kevin Barton
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Genetics 21
- Glioma Diagnosis and Treatment 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Chronic Lymphocytic Leukemia Research 4
- Hematology 15
- Acute Myeloid Leukemia Research 10
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Jeffrey M. Leiden (7 shared papers)Natarajan Muthusamy (3 shared papers)Chao-Nan Ting (2 shared papers)Marilyn C. Olson (1 shared paper)Christopher Fischer (2 shared papers)Min M. Lu (2 shared papers)Emily Barr (1 shared paper)Serhan Alkan (6 shared papers)
- Journals
- Blood (6 papers)World Neurosurgery (4 papers)British Journal of Haematology (3 papers)Nature (3 papers)BioEssays (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Kevin Barton
54 papers receiving 4.0k citations
Kevin Barton's Hit Papers
Peers
Comparison fields: 5 of 115
- Genetics 826
- Immunology 1.3k
- Hematology 524
- Oncology 1.0k
- Cancer Research 436
Countries citing papers authored by Kevin Barton
This map shows the geographic impact of Kevin Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Barton more than expected).
Fields of papers citing papers by Kevin Barton
This network shows the impact of papers produced by Kevin Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Barton. The network helps show where Kevin Barton may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Barton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Hit paper breakdown → | 2017 | 930 |
| 2 | 1996 | 536 | |
| 3 | 1995 | 316 | |
| 4 | 1998 | 307 | |
| 5 | 1995 | 296 | |
| 6 | 2013 | 270 | |
| 7 | 1996 | 229 | |
| 8 | 2004 | 145 | |
| 9 | 2001 | 141 | |
| 10 | 2000 | 126 | |
| 11 | 2005 | 107 | |
| 12 | 2004 | 90 | |
| 13 | 1999 | 64 | |
| 14 | 2007 | 63 | |
| 15 | 2022 | 59 | |
| 16 | 2008 | 54 | |
| 17 | 2001 | 49 | |
| 18 | 1998 | 32 | |
| 19 | 2005 | 32 | |
| 20 | 1989 | 23 |
About Kevin Barton
Kevin Barton is a scholar working on Genetics, Hematology, Immunology, Oncology and Neurology, having authored 55 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Glioma Diagnosis and Treatment (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (6 papers), Meningioma and schwannoma management (6 papers), Multiple Myeloma Research and Treatments (5 papers), Brain Metastases and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Genetics (826 citations), Immunology (1.3k citations), Hematology (524 citations), Oncology (1.0k citations) and Cancer Research (436 citations). Kevin Barton has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jeffrey M. Leiden, Natarajan Muthusamy, Chao-Nan Ting, Marilyn C. Olson, Christopher Fischer, Min M. Lu, Emily Barr, Serhan Alkan, Theresa L. Walunas and Lewis L. Lanier. Their work appears in journals such as Blood, World Neurosurgery, British Journal of Haematology, Nature and BioEssays.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.